Destination XL Group
DXLG
58 hedge funds and large institutions have $17.7M invested in Destination XL Group in 2026 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 9 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 14
1.01% less ownership
Funds ownership: 64.24% → 63.22% (-1%)
5% less funds holding
Funds holding: 61 → 58 (-3)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
45% less capital invested
Capital invested by funds: $32.3M → $17.7M (-$14.6M)
Top Buyers
| 1 |
SB
Strategic Blueprint
Atlanta,
Georgia
|
+$154K |
| 2 |
CIA
Concurrent Investment Advisors
Tampa,
Florida
|
+$142K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$103K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$27.9K |
| 5 |
BlackRock
New York
|
+$13.2K |
Top Sellers
DXLG Hedge Fund Activity: Q1 2026 in Review
58 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in Destination XL Group (DXLG) for Q1 2026, worth a combined $17.7M — down 45% from $32.3M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of DXLG and 8 opened new positions — a net loss of 1 holder — while 14 trimmed existing stakes and 14 added.
The largest buyer was Strategic Blueprint, opening a new position worth an estimated $154K. The largest seller was Nantahala Capital Management, cutting an estimated $233K.
- 58 institutional investors held Destination XL Group (DXLG) as of Q1 2026, down from 61 in Q4 2025.
- Funds reported $17.7M of Destination XL Group stock for Q1 2026, down 45% quarter-over-quarter.
- 8 funds opened new Destination XL Group positions in Q1 2026 and 9 closed out, a net change of -1 holder.
- The largest Destination XL Group buyer in Q1 2026 was Strategic Blueprint, an estimated $154K added.
- The largest Destination XL Group seller in Q1 2026 was Nantahala Capital Management, an estimated $233K sold.
Based on aggregated 13F filings for Q1 2026.